These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1603377)

  • 21. New recommendation for malaria treatment in Indonesia.
    Nelwan EJ
    Acta Med Indones; 2012 Jul; 44(3):185-6. PubMed ID: 23033407
    [No Abstract]   [Full Text] [Related]  

  • 22. Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia.
    Singhasivanon P
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 4():i-iv, 1-101. PubMed ID: 10935286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A standard regimen for treatment of plasmodium vivax malaria.
    Patwari AK
    Indian Pediatr; 1996 Sep; 33(9):792-4. PubMed ID: 9057417
    [No Abstract]   [Full Text] [Related]  

  • 24. Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment.
    Vinetz JM
    Clin Infect Dis; 2006 Apr; 42(8):1073-4. PubMed ID: 16575722
    [No Abstract]   [Full Text] [Related]  

  • 25. Halofantrine in acute malaria.
    Sorabjee JS
    J Assoc Physicians India; 1994 May; 42(5):425. PubMed ID: 7718040
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can estimates of antimalarial efficacy from field studies be improved?
    Gatton ML; Cheng Q
    Trends Parasitol; 2008 Feb; 24(2):68-73. PubMed ID: 18182325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world therapies and the problem of vivax malaria.
    Baird JK
    N Engl J Med; 2008 Dec; 359(24):2601-3. PubMed ID: 19064622
    [No Abstract]   [Full Text] [Related]  

  • 29. Artemisinin resistance in Plasmodium falciparum malaria.
    Taylor SM; Juliano JJ; Meshnick SR
    N Engl J Med; 2009 Oct; 361(18):1807; author reply 1808. PubMed ID: 19864681
    [No Abstract]   [Full Text] [Related]  

  • 30. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.
    Fryauff DJ; Leksana B; Masbar S; Wiady I; Sismadi P; Susanti AI; Nagesha HS; Syafruddin ; Atmosoedjono S; Bangs MJ; Baird JK
    Ann Trop Med Parasitol; 2002 Jul; 96(5):447-62. PubMed ID: 12194705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimalarial chemotherapy: the old and the new perspectives.
    Mukherjee N
    J Assoc Physicians India; 1998 Nov; 46(11):959-63. PubMed ID: 11229225
    [No Abstract]   [Full Text] [Related]  

  • 32. Chloroquine and primaquine: combining old drugs as a new weapon against falciparum malaria?
    Egan TJ
    Trends Parasitol; 2006 Jun; 22(6):235-7. PubMed ID: 16580880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular markers of chloroquine resistance in Plasmodium falciparum in Sri Lanka: frequency before revision of the antimalarial drug policy.
    Hapuarachchi HC; Abeysundara S; Dayanath MY; Manamperi A; Abeyewickreme W; de Silva NR
    Ann Trop Med Parasitol; 2009 Jun; 103(4):351-6. PubMed ID: 19508753
    [No Abstract]   [Full Text] [Related]  

  • 34. Retrospective evaluation of malaria patients in Turkey.
    Yamazhan T; Göksel S; Arda B; Gökengin D; Ulusoy S; Ertem E; Serter D
    Trop Doct; 2004 Jan; 34(1):59-60. PubMed ID: 14959990
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo sulphadoxine-pyrimethamine sentitivity study Tigray Region, Southern Zone, Alamata Town, September--November 2001.
    Degefa T
    Ethiop Med J; 2004 Jan; 42(1):35-9. PubMed ID: 15884275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
    Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Halofantrine in acute malaria.
    Lazar AI
    J Assoc Physicians India; 1994 May; 42(5):425-6; author reply 426-7. PubMed ID: 7829450
    [No Abstract]   [Full Text] [Related]  

  • 38. Modifying national malaria treatment policies in Peru.
    Ruebush TK; Neyra D; Cabezas C
    J Public Health Policy; 2004; 25(3-4):328-45. PubMed ID: 15683069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy for malaria: mission accomplished?
    Plowe CV
    Clin Infect Dis; 2007 Apr; 44(8):1075-7. PubMed ID: 17366452
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mefloquine resistance in Plasmodium falciparum malaria].
    Garavelli PL
    Recenti Prog Med; 2003; 94(7-8):343. PubMed ID: 12868243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.